FLOT2 and nasopharyngeal carcinoma: siRNA-mediated FLOT2 protein can greatly reduce the activity of Src tyrosine kinase and alleviate the epithelial-mesenchymal transformation process of nasopharyngeal carcinoma cell strains [14]; and siRNA-mediated FLOT2 protein can also reduce the growth and invasion of esophageal squamous cancer [28].